Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe? | Zendy

Maria Prins | Zendy; R.P. Brettle | Zendy; Roy Robertson | Zendy; Ildefonso HernándezAguado | Zendy; Barbara Broers | Zendy; Nicolas Carré | Zendy; David Goldberg | Zendy; Robert Zangerle | Zendy; R A Coutinho | Zendy; A van den Hoek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Geographical variation in disease progression in HIV-1 seroconverted injecting drug users in Europe?

Author(s) -

Maria Prins,

R.P. Brettle,

Roy Robertson,

Ildefonso HernándezAguado,

Barbara Broers,

Nicolas Carré,

David Goldberg,

Robert Zangerle,

R A Coutinho,

A van den Hoek

Publication year - 1999

Publication title -

international journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.406

H-Index - 208

eISSN - 1464-3685

pISSN - 0300-5771

DOI - 10.1093/ije/28.3.541

Subject(s) - seroconversion , medicine , confounding , proportional hazards model , epidemiology , demography , survival analysis , immunology , relative risk , human immunodeficiency virus (hiv) , confidence interval , sociology

Human immunodeficiency virus (HIV) disease progression might vary by geographical region due to differences in the spectrum of HIV-related illnesses and (access to) health care. Therefore, the effect of geographical region, next to the effect of other potential cofactors, on disease progression in 664 injecting drug users (IDU) with documented HIV seroconversion from eight cohorts in Europe was studied.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research